Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05146375

Genes Modulating the Severity of Aortic Aneurysms (MSF1-TGFBR2)

Sponsor: French Cardiology Society

View on ClinicalTrials.gov

Summary

This project concerns a population at risk of sudden death by dissection of the thoracic aorta. Its interest is to make it possible to recognize the genes that protect or worsen the evolution of aneurysms, to better understand the mechanisms involved, to detect and treat aneurysms of the thoracic aorta, wich is a pathology that is completely silent clinically until life-threatening complications. The variability in the severity of the disease within the same family is related to modifier genes. The objective is to find the modifying factors that account for the variability in the severity of the progression of aneurysms of the thoracic aorta.

Key Details

Gender

All

Age Range

10 Years - Any

Study Type

OBSERVATIONAL

Enrollment

17

Start Date

2022-11-24

Completion Date

2025-11-30

Last Updated

2026-10-09

Healthy Volunteers

Not specified

Interventions

BIOLOGICAL

TGFBR2

TGFBR2 mutation correlation with severity of the aortic disease. Blood sampling. Serum will be analysed by DNA sequencing to detect specific mutations involved in aneurysms. Cutaneous biopsy. Fibroblast culture will be done to assess the transcriptome analysis.

Locations (1)

Hopital Bichat-Claude Bernard

Paris, France